Factors Associated with 28-day Readmission Among Patients with Schizophrenia: A 10-Year Retrospective Study in Nong Bua Lam Phu Hospital

Authors

  • จุฬาลักษณ์ สินจัตุรัส -

Keywords:

schizophrenia, readmission, factor

Abstract

This retrospective case control study collected data from medical records of patients with schizophrenia in Nong Bua Lam Phu Hospital during January 5, 2015 to January 31, 2025. The study aims to explore factors associated with 28-day readmission of patients with schizophrenia. Total sample size of 178 cases were divided into two groups; the readmission group (89 cases) and the non-readmission group (89 controls). The majority of readmission group were male (63%), most of age was 18-40 years (45%), single (44%), unemployed (59%), living alone (68%), duration of illness was 1-10 years (65%), substance use (76%) and no physical underlying disease (59%). Factors associated with readmission were investigated using logistic regression analysis. The significant associated factors (p <0.05) were number of admissions more than 2 times (AOR 112.25; 95% CI: 11.76, 1071.71), non-adherence to appointment (AOR 12.82; 95% CI: 1.96, 84.00), substance use (AOR 10.15; 95% CI: 1.61, 64.10), poor drug compliance (AOR 6.59; 95% CI: 1.33, 32.73), discharge planning (AOR 0.15; 95% CI: 0.03, 0.76), long-acting injections (AOR 0.06; 95% CI: 0.01, 0.31) and length of stay more than 14 days (AOR 0.03; 95% CI: 0.01, 0.23). Prevention of readmission should focus on controlling risk factors alongside promoting protective factors, particularly by improving discharge planning, increasing the coverage of long-acting injections and ensuring an appropriate length of stay.

References

มาโนช หล่อตระกูล. จิตเวชศาสตร์รามาธิบดี. พิมพ์ครั้งที่ 4. กรุงเทพมหานคร: คณะแพทยศาสตร์โรงพยาบาลรามาธิบดี มหาวิทยาลัยมหิดล; 2558.

World Health Organization. Schizophrenia [Internet]. 2025 [cited 2025 Sep 9]. Available from: https://www.who.int/news-room/fact-sheets/detail/schizophrenia/

Phanthunane P, Vos T, Whiteford H, Bertram M, Udomratn P. Schizophrenia in Thailand: prevalence and burden of disease. Popul Health Metr. 2010;8:24.

Kadakia A, Fan Q, Onukwugha E, Guo JZ. The Economic Burden of Schizophrenia: A Systematic Review. PharmacoEconomics. 2022;40(6):601-16.

Sittironnarit G. Economic burden of schizophrenia in Thailand: A cost-of-illness study. J Med Assoc Thai. 2021;104(3):S1-S10.

Jauhar S, Johnstone M, McKenna PJ. Schizophrenia. Lancet. 2022;399(10323):473-86.

Boaz TL, Becker MA, Andel R, Van Dorn RA, Choi J, Sikirica M. Risk factors for early readmission to acute care for persons with schizophrenia taking antipsychotic medications. Psychiatr Serv. 2013;64(12):1225-29.

Li Z, Ge X, Feng J, Li J, Liu J, Wang J, et al. Risk factors for 30-day readmission in patients with schizophrenia: A retrospective study based on a large clinical database. Front Psychiatry. 2023;14:1165487.

Australian Institute of Health and Welfare. Mental health services in Australia: Performance indicators [Internet]. Canberra: AIHW; 2025 [cited 2026 Mar 9]. Available from: https://www.aihw.gov.au/mental-health/monitoring/performance-indicators

Donisi V, Tedeschi F, Salazzari D. Pre- and post-discharge predictors of 30-day readmission in a sample of people with schizophrenia: a retrospective analysis. BMC Psychiatry. 2021;21(1):423.

Kongsakon R, Kanchanatawan B. Cost analysis of treatment for schizophrenic patients in social security scheme, Thailand. ASEAN J Psychiatry. 2007;8(2):118-23.

Jaramillo-Gonzalez LE, Sanchez-Pedraza R, Herazo MI. The frequency of rehospitalization and associated factors in Colombian psychiatric patients: a cohort study. BMC Psychiatry. 2014;14:161.

Pono K. Length of stay and factors associated with readmission among patients with schizophrenia in Nakhon Phanom Psychiatric Hospital. J Somdet Chaopraya Inst Psychiatry. 2012;6(1):1-13.

Han X, Jiang F, Tang Y, Needleman J, Guo M, Chen Y, et al. Factors associated with 30-day and 1-year readmission among psychiatric inpatients in Beijing, China: a retrospective, medical record-based analysis. BMC Psychiatry. 2020;20(1):113.

San L, Bernardo M, Gomez A, Pena M. Factors associated with relapse in patients with schizophrenia. Int J Psychiatry Clin Pract. 2013;17(1):2-9.

Hung YY, Chan HY, Pan YJ. Risk factors for readmission in schizophrenia patients following involuntary admission. PLOS ONE. 2017;12(10):e0186768.

Namwong P, Chanakoon W. Factors associated with 28-day rehospitalization of patients with schizophrenia in Somdet Chaopraya Institute of Psychiatry. J Somdet Chaopraya Inst Psychiatry. 2018;12(2):1-11.

Suwattanapreeda J, Piboonarluk W, Keawyot K, Suwattanapreeda S. Predictive factors of readmission in patients with schizophrenia using data mining techniques. J Somdet Chaopraya Inst Psychiatry. 2021;15(2):13-24.

Pitanupong J, Ratanaapiromyakij P, Teetharatkul T. Factors associated with readmission among individuals with one previous episode of schizophrenia in Southern Thailand: a university hospital-based retrospective study. J Health Sci Med Res. 2022;40(6):657-70.

Xiao J, Mi W, Li L, Shi Y, Zhang H. Predictors of 30-day readmission in patients with schizophrenia: A systematic review and meta-analysis. J Psychiatr Res. 2022;151:516-25.

Ma Y, Rosenheck R, Fan N, He H. Rates and patient characteristics of electroconvulsive therapy in China and comparisons with the United States. J ECT. 2019;35(4):251-57.

Downloads

Published

2026-03-27

How to Cite

1.
สินจัตุรัส จ. Factors Associated with 28-day Readmission Among Patients with Schizophrenia: A 10-Year Retrospective Study in Nong Bua Lam Phu Hospital. JKKPHO [internet]. 2026 Mar. 27 [cited 2026 Sep. 20];8(1):e280339. available from: https://he02.tci-thaijo.org/index.php/jkkpho/article/view/280339

Issue

Section

Original Article